Delivery Order SPE2DB24D3015-SPE2DB26FFWWN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,681.36 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials. This is a firm fixed-price contract with no set-aside designation, competitively awarded for delivery to the company's headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- On July 29, 2025, the Defense Logistics Agency awarded a delivery order valued at approximately $28.4K to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 30, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $18,471.46 to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed-price, non-set-aside contract with performance expected at the vendor's facility in Conshohocken, Pennsylvania, and an ultimate completion date of October 21, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials, with a ceiling value of $23,512.44. This competitively awarded, firm fixed-price delivery order is set to conclude on July 22, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,278.88 to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This is a firm fixed price contract with no set-aside designation, competitively awarded under an open procurement process. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 29, 2025. As a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials, with a ceiling value of $3,759.96. This is a firm fixed-price delivery order with an ultimate completion date of April 22, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $1,253.32 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of June 2, 2025, and performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with a ceiling value of $89,881.88 and an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11,833.28 on October 27, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with completion scheduled for October 28, 2025. The contract utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) pre-filled pens with a ceiling value of $3,519.05. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB26FFWWNDelivery Order
On November 5, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $6,552.47 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 6, 2025, and will be performed at the company's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has established itself as a critical federal medical procurement vendor through multiple competitively awarded contracts with the Defense Logistics Agency. The company's portfolio includes diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies, serving customers such as the Defense Health Agency and U.S. Coast Guard. The underlying IDC contract represents a flexible procurement vehicle designed to provide cost-effective access to essential pharmaceutical commodities for military healthcare operations and the broader federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 11/5/25 |